NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
REMOTE, NCT05006105: Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients |
|
|
| Recruiting | N/A | 225 | Europe | seven-day ECG Holter, 24-hour blood pressure monitor, Questionnaire: vision of mHealth, Questionnaire: user experience & feeling of safety, Insertable loop recorder | Ziekenhuis Oost-Limburg, Hasselt University, Jessa Hospital | Cryptogenic Stroke, Atrial Fibrillation | 02/25 | 02/25 | | |
